Skip to content
Trial Eligibility
Menu

Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms

NCT04661215

This study is recruiting at 5 US sites in 5 states, according to its ClinicalTrials.gov record last updated .

Summary

The overall objective of this study is to determine if there are pyloric sphincter abnormalities in patients with gastroparesis symptoms and determine how prevalent these abnormalities are using tests to assess the pyloric sphincter - endoluminal functional luminal imaging probe (Endoflip™), water load satiety testing (WLST), and high-resolution cutaneous electrogastrography (HR-EGG) using Gastric Alimetry™ System.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Gastroparesis
  • Idiopathic Gastric Motility Disorder
  • Diabetic Gastroparesis

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 85 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Johns Hopkins Bloomberg School of Public Health
Last updated on ClinicalTrials.gov
April 3, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arizona · 1

  • Mayo Clinic Arizona · Scottsdale, AZ

Kentucky · 1

  • University of Louisville · Louisville, KY

Massachusetts · 1

  • Massachusetts General · Boston, MA

North Carolina · 1

  • Wake Forest University Health Sciences · Winston-Salem, NC

Pennsylvania · 1

  • Temple University · Philadelphia, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.